Healthcare Triangle Enters Sales Agreement with Spartan Capital

TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off An update from Healthcare Triangle ( (HCTI) ) is now available. On November 18, 2025, Healthcare Triangle, Inc. entered into a Sales Agreement with Spartan Capital Securities, LLC to facilitate an ‘at the market offering’ of its common stock, with a market value of up to $20,000,000. This agreement allows the company to sell shares directly on the Nasdaq Capital Market or other trading platforms, providing flexibility in raising capital while Spartan receives a 3% commission on sales, enhancing the company’s financial strategy and market presence. Spark’s Take on HCTI Stock According to Spark, TipRanks’ AI Analyst, HCTI is a Underperform. Healthcare Triangle is currently in a challenging financial position with negative revenue growth, persistent losses, and negative equity. The technical analysis further highlights a bearish trend, with the stock trading below key moving averages. Valuation metrics are poor, with a negative P/E ratio and no dividend yield. While the new CFO appointment is a positive corporate event, it is not sufficient to offset the overall negative outlook. To see Spark’s full report on HCTI stock, click here. More about Healthcare Triangle Healthcare Triangle, Inc. operates in the healthcare industry, focusing on providing cloud-based technology solutions and services to enhance operational efficiency and patient care. The company is known for its innovative approaches in leveraging data and technology to address the needs of healthcare organizations. Average Trading Volume: 1,106,074 Technical Sentiment Signal: Sell Current Market Cap: $13.51M Find detailed analytics on HCTI stock on TipRanks’ Stock Analysis page.